Evolent Health (EVH) PT Lowered to $6 at Truist Securities
Truist Securities analyst Jailendra Singh lowered the price target on Evolent Health (NYSE: EVH) to $6.00 (from $7.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
